Literature DB >> 7557145

Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.

K Ohashi1, Y Nakajima, H Kanehiro, M Tsutsumi, J Taki, Y Aomatsu, A Yoshimura, S Ko, T Kin, K Yagura.   

Abstract

BACKGROUND & AIMS: We previously reported that intrahepatic cholangiocarcinomas (ICCs) can be divided into three categories according to their gross appearance with possible links to biological behavior. Ki-ras and p53 gene alterations are thought to be involved in early and late phases of carcinogenesis, respectively. This study was performed to investigate the relationship between the gross appearance and genetic alterations of ICC.
METHODS: We examined 21 patients with ICC. Ki-ras point mutations were assessed by polymerase chain reaction/single-strand conformation polymorphism methods followed by direct DNA sequencing. Expressions of p53 protein were immunohistochemically assessed.
RESULTS: Ki-ras point mutations were found in 10 patients (48%), and expressions of p53 protein were detected in 4 (19%). Applying the gross classification that we previously proposed, Ki-ras mutations were prominent in the periductal extension type (4 of 6; 67%) and the spicula-forming type (6 of 10; 60%). On the other hand, none of the five mass-forming-type tumors harbored Ki-ras mutations. Expressions of p53 protein did not show any clear association with gross appearance.
CONCLUSIONS: Ki-ras gene alterations may be involved in the cholangiocarcinogenesis of periductal extension and spicula-forming but not mass-forming types, suggesting that the underlying processes of development are different.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557145     DOI: 10.1016/0016-5085(95)90650-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Authors:  Supak Yothaisong; Hasaya Dokduang; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Gregory J Riggins; Watcharin Loilome
Journal:  Tumour Biol       Date:  2013-07-06

2.  Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Authors:  Holger G Hass; Oliver Nehls; Juergen Jobst; Andrea Frilling; Ulrich Vogel; Stephan Kaiser
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

Review 3.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

4.  Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.

Authors:  Junji Ueda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Masato Yoshioka; Atsushi Hirakata; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tomohiro Kanda; Hideyuki Takata; Ryota Kondo; Eiji Uchida
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

5.  Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth.

Authors:  E Hidaka; A Yanagisawa; M Seki; T Setoguchi; Y Kato
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 6.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

Review 7.  Genetic profiling of intrahepatic cholangiocarcinoma.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Curr Opin Gastroenterol       Date:  2012-05       Impact factor: 3.287

Review 8.  Genetics of biliary tract cancers and emerging targeted therapies.

Authors:  Aram F Hezel; Vikram Deshpande; Andrew X Zhu
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

9.  Molecular mechanisms of cholangiocarcinoma.

Authors:  Giammarco Fava
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

10.  Intrahepatic Biliary Intraductal Oncocytic Papillary Neoplasm/Carcinoma: First Reported Case in Australia and Literature Review.

Authors:  Christopher Chu; William Felbel; Francis Chu
Journal:  Radiol Case Rep       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.